ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 078

Periodic Fever Syndrome and Myelodysplastic Syndrome: Possible Connections Between Two Disorders

Ivanna Romankevych1, Nicole Torres2, Imani Sanders1, Laurent King1 and Pedro Garcia Rodriguez1, 1Jackson Health System, University of Miami Miller School of Medicine, Miami, FL, 2University of Miami Miller School of Medicine, Miami, FL

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: autoimmune diseases, Autoinflammatory diseases

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, March 30, 2023

Title: Posters: Genetics and Pathogenesis I

Session Type: Poster Session A

Session Time: 6:00PM-7:00PM

Background/Purpose: Background: associations between autoimmune, immunodeficiency and hematological disorders are well known as well as with autoinflammatory conditions. Modern genetic testing allows to link these conditions not only clinically but on genetic level also.

Methods: literature review for possible connections between autoinflammatory and autoimmune disorder with myelodysplastic syndrome associated with SRP72 gene polymorphism.

Results: L., 3-year-old boy with past medical history of periodic fever, myelodysplastic syndrome (MDS) associated with pathologic polymorphism of gene SRP72 (C1384C T), multiple café au lait spots and autism spectrum disorder was admitted to our hospital due to fever. Fever episodes occurred since 6-month-old (up to 40C), every 3 months and lasted 5-15 days. The episodes associated with rash, conjunctivitis, arthralgias, reactive lymphadenopathy, oral and duodenal ulcers, Raynaud syndrome and elevation of C-reactive protein level during fever episodes. The initially managed the fever with Prednisone due to concerns for an autoimmune condition or PFAPA. The fever has improved to steroid in the early course of disorder but following episodes hasnt had any response. Extensive work up has been done. Autoimmune, immunology, oncology evaluation was negative, but genetic testing (microarray and Invitae primary immunodeficiency panel) was positive for pathologic polymorphism of gene SRP72. At 18-months of age, he was diagnosed with neutropenia first time. Family history was significant for periodic fever and lupus-like symptoms in his mother and rheumatoid arthritis in maternal uncle. Tests results were inconclusive for possible reason of his symptoms. Next comprehensive evaluation has been performed at National Institute of Health in June 2022. Full genome sequencing results are pending.

While definitive diagnosis is still not clear, we decided to look for possible links between MDS and his periodic fevers. In adults MDS associates with various autoimmune and autoinflammatory processes like vasculitis, inflammatory arthritis, autoimmune cytopenia. MDS associated with SRP72 polymorphism/mutation has familial involvement and usually early onset. The SRP72 is gene encoding one of the subunits of SRP (signal recognition particle) responsible for targeting of secretory protein to the endoplasmic reticulum (ER).

SRP72 cleaved during apoptosis possibly links to impaired tolerance to own peptides and self-autoantibodies formation that triggering the autoimmune diseases. Inappropriate protein production and degradation might be another non-immunologic mechanism triggering inflammation. Adequate function od ER and protein homeostasis are necessary for muscle tissue stability. There is association of SRP72 with idiopathic inflammatory myopathies (IIM). However, process of SRP72 synthesis and IIM in not fully known investigated. There are not know connections between MDS and periodic fever syndromes.

Conclusion: myelodysplastic syndrome associated with SRP72 gene polymorphism has strong association with IIM but not with autoinflammatory syndromes. Patient should have close monitoring for developing features of IIM


Disclosures: I. Romankevych: None; N. Torres: None; I. Sanders: None; L. King: None; P. Garcia Rodriguez: None.

To cite this abstract in AMA style:

Romankevych I, Torres N, Sanders I, King L, Garcia Rodriguez P. Periodic Fever Syndrome and Myelodysplastic Syndrome: Possible Connections Between Two Disorders [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/periodic-fever-syndrome-and-myelodysplastic-syndrome-possible-connections-between-two-disorders/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/periodic-fever-syndrome-and-myelodysplastic-syndrome-possible-connections-between-two-disorders/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology